Evaluation – HLS Therapeutics – Industry Workshop – I061600-C Session Title: Modernizing schizophrenia patient management with rapid blood tests for antipsychotic medication levels Presenter: William Clarke, MBA, PhD, DABCC, FAACC, Director, Clinical Toxicology, Director, Point-of-Care Testing, Co-Director, Clinical Chemistry Post-Doctoral Fellowship Program, Medicine; Professor of Pathology, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine Objectives: At the conclusion of this session, participants will be able to explain and apply: Identify the clinical gaps in the schizophrenia patient`s care journey. Define the appropriate clinical application of clozapine TDM. Interpret clinical guidance for optimal utilization of assays for antipsychotic TDM. 1. Please rate the Session by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly AgreeSufficient time was allowed for audience participation/active learning. One Two Three Four Five The facilities were satisfactory. One Two Three Four Five The session was free from commercial bias. One Two Three Four Five Overall, I would rate this Symposium as excellent. One Two Three Four Five 2. Please assess the Speaker by choosing the appropriate number: Rating Scale:1 Strongly Disagree, 2 Disagree, 3 Neutral, 4 Agree, 5 Strongly Agree William Clarke, MBA, PhD, DABCC, FAACC, Director, Clinical Toxicology, Director, Point-of-Care Testing, Co-Director, Clinical Chemistry Post-Doctoral Fellowship Program, Medicine; Professor of Pathology, The Johns Hopkins Hospital, Johns Hopkins University School of MedicineClarity of One Two Three Four Five Met Stated Objectives One Two Three Four Five Balanced & Unbiased One Two Three Four Five Relevant to Practice Overall One Two Three Four Five Time for Active Learning One Two Three Four Five 4. As a result of attending this session, I am planning to: (please check one)a) Discuss the session with my colleagues Yes No b) Pursue additional learning activities. Yes No c) Complete a Personal Learning Project. Yes No d) Not change my practice. Yes No 3) Change my practice. Yes No 5. Please explain the change you are planning to make or the learning you plan to complete:6. Please indicate which CanMEDS roles you felt were addressed during this educational activity. (Select all that apply) Medical Expert Communicator Collaborator Manager Health Advocate Scholar Professional 7. General comments about individual speakers8. What topics need to be addressed at future conferences to keep you up to date in your profession?Name Session Title Date Year Location Conference/Event CreditsEmail Session Code
